Recombinant Yarrowia lipolytica ATP synthase subunit 9 (ATP9), mitochondrial, is a bioengineered protein derived from the yeast Y. lipolytica. ATP9 is a critical component of the mitochondrial ATP synthase complex, which catalyzes ATP synthesis during oxidative phosphorylation. The recombinant form is produced via heterologous expression in Escherichia coli and is used in structural, functional, and biochemical studies to elucidate mitochondrial energy production mechanisms.
UniProt ID: Q37695
Length: Full-length (1–76 amino acids)
Tag: N-terminal His-tag for purification
Expression Host: E. coli
ATP9 is part of the mitochondrial ATP synthase complex, specifically within the Fo subunit, which facilitates proton translocation across the inner mitochondrial membrane. Structural studies of Y. lipolytica ATP synthase revealed:
Proton Translocation: ATP9 participates in the rotary catalysis mechanism, where proton flow drives ATP synthesis.
Lipid-Binding: ATP9 interacts with mitochondrial membrane lipids, stabilizing the Fo subunit structure .
Recombinant ATP9 is produced in E. coli and purified via affinity chromatography due to its His-tag. Key production parameters are summarized below:
The ATP9 sequence (Q37695) includes hydrophobic regions critical for membrane integration:
Hydrophobic Stretches: Enable integration into the mitochondrial inner membrane.
N-Terminal His-Tag: Facilitates purification via nickel affinity chromatography .
Proton Translocation Efficiency: ATP9’s lipid-binding properties enhance the stability of the Fo subunit during proton flow .
Mitochondrial Cristae Formation: ATP9-induced membrane curvature contributes to cristae morphology, critical for increasing mitochondrial surface area .
Protein Engineering: Recombinant ATP9 serves as a model for studying eukaryotic ATP synthase assembly and dysfunction.
Therapeutic Research: Insights into ATP9’s structure/function could inform treatments for mitochondrial disorders linked to ATP synthase dysregulation .
Creative Biomart. (2025). Recombinant Full Length Yarrowia lipolytica ATP synthase subunit 9.
e-Scape Bio. (n.d.). ELISA Recombinant Yarrowia lipolytica ATP synthase subunit 9.
Hahn et al. (2016). Structure of a Complete ATP Synthase Dimer. Molecular Cell.
Colorectal Research. (n.d.). ELISA Recombinant Yarrowia lipolytica ATP synthase subunit 9.
KEGG: yli:YalifMp17
STRING: 4952.NP_075437.1
Y. lipolytica ATP9 is a 76-amino acid mitochondrial protein with the sequence: MQLVLAGKYIGAGLASIGLVGAGIGIAIVFAALINGVSRNPALKGQLFTYSILGFALSEATGLFALMIAFLLLYAV . As a subunit of ATP synthase (also known as Complex V), it forms part of the c-ring in the F₀ domain embedded within the inner mitochondrial membrane. The protein contains highly hydrophobic regions that facilitate its membrane integration, as reflected in its amino acid composition rich in leucine, isoleucine, and alanine residues .
ATP9 is encoded within Y. lipolytica's 47.9 kb mitochondrial genome. The mitochondrial DNA of Y. lipolytica contains genes for three ATP synthase subunits (ATP6, ATP8, and ATP9), all located on the same strand . The mitochondrial genome organization of Y. lipolytica shows similarities to that of Hansenula wingei, with conserved gene order blocks and sequence homology . This genomic architecture contributes to the coordinated expression of mitochondrial respiratory components.
The ATP9 protein is also known by several synonyms including OLI1, ATP synthase subunit 9 (mitochondrial), ATP synthase subunit c, and Lipid-binding protein . In protein databases, it is cataloged under UniProt ID Q37695 . This nomenclature variation reflects both its functional role and historical identification pathways in different research contexts.
E. coli has been successfully employed as a heterologous expression system for recombinant Y. lipolytica ATP9 . For optimal expression, the full-length protein (amino acids 1-76) is typically fused with an N-terminal His-tag to facilitate purification . Alternative expression approaches include using Y. lipolytica itself as both the source and expression host, particularly when studying protein interactions within their native context or when post-translational modifications are critical to protein function .
Purification of ATP9 from Y. lipolytica typically involves:
Initial solubilization: Using dodecylmaltoside (DDM) to solubilize mitochondrial membranes
Gradient separation: Centrifugation in digitonin-containing glycerol gradients
Chromatographic separation: Anion exchange chromatography for final purification
For recombinant His-tagged ATP9 expressed in E. coli, immobilized metal affinity chromatography (IMAC) is the preferred initial purification step, potentially followed by size exclusion chromatography to achieve >90% purity as verified by SDS-PAGE .
For reconstitution of lyophilized ATP9:
Briefly centrifuge the vial before opening to ensure all content settles at the bottom
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (optimally 50%) for long-term storage stability
Aliquot the reconstituted protein to minimize freeze-thaw cycles
This approach maintains protein structure and function while preventing degradation during storage.
For optimal stability of recombinant Y. lipolytica ATP9:
Long-term storage: Store at -20°C or preferably -80°C in Tris/PBS-based buffer containing 6% trehalose at pH 8.0
Working aliquots: Store at 4°C for up to one week to minimize freeze-thaw damage
Glycerol addition: Incorporate 50% glycerol (final concentration) when preparing storage aliquots
Research indicates that repeated freeze-thaw cycles significantly impact protein integrity, particularly for membrane proteins like ATP9 with extensive hydrophobic regions .
ATP9 plays a critical role in ATP synthase dimer formation and stability. Experimental approaches include:
Comparative analysis: Purify both monomeric and dimeric ATP synthase complexes from Y. lipolytica to analyze component differences (dimeric complexes contain subunits e, g, and k in addition to standard ATP synthase subunits)
Electron microscopy: Cryo-EM has successfully resolved ATP synthase dimer structures from Y. lipolytica, revealing the molecular architecture of the dimer interface in the membrane
Activity assays: Compare ATP hydrolysis activity between monomeric and dimeric forms to correlate structural differences with functional implications
These approaches provide insights into how ATP9 contributes to the higher-order organization of ATP synthase complexes and mitochondrial membrane architecture.
To analyze ATP9 interactions within the ATP synthase complex:
Crosslinking studies: Chemical crosslinking followed by mass spectrometry analysis identifies interaction sites
Two-dimensional gel electrophoresis: Resolves ATP synthase complex components while maintaining native interactions
LC-MS verification: Confirms the presence of specific subunits and their stoichiometry within isolated complexes
Co-immunoprecipitation: Using antibodies against ATP9 or other subunits to pull down interaction partners
These techniques can reveal how ATP9 participates in c-ring formation and interfaces with other components of the F₀ domain.
ATP9 involvement in mitochondrial membrane architecture involves:
Dimer formation: ATP9 participates in ATP synthase dimerization, which induces membrane curvature essential for cristae formation
Membrane bending: The specific arrangement of ATP9 within dimeric ATP synthase complexes creates localized membrane curvature
Structural organization: Complete ATP synthase dimers containing ATP9 have been shown to reveal "the previously unknown subunit architecture of the dimer interface in the membrane, thereby providing major new insights into mitochondrial membrane architecture"
Research utilizing cryo-electron microscopy of purified ATP synthase complexes from Y. lipolytica has been instrumental in understanding these structural relationships.
For genetic manipulation of ATP9 expression in Y. lipolytica:
Multi-copy integration: Y. lipolytica can be engineered to incorporate multiple expression cassettes through integrative transformation methods
Promoter selection: The isocitrate lyase promoter (pICL1) has proven effective for heterologous protein expression in Y. lipolytica
Integration targeting: rDNA or LTR zeta sequences of Ylt1 can be used as integration targets
Selection strategies: The ura3d4 marker enables selection of multi-copy transformants
Diploidisation: Combining different expression cassettes through diploidisation of selected haploid multi-copy transformants
These approaches have successfully generated Y. lipolytica strains expressing multiple heterologous proteins simultaneously, a technique potentially applicable to ATP9 expression manipulation.
The Y. lipolytica mitochondrial genome uses the standard mould mitochondrial genetic code, with an interesting exception related to CGN (arginine) codons:
Codon usage analysis: No tRNAs capable of reading CGN codons exist in the Y. lipolytica mitochondrial genome
Comparative genomics: CGN codons are absent in exonic open reading frames but present in intronic open reading frames
Evolutionary implications: Several intronic open reading frames containing CGN codons have accumulated mutations and become pseudogenes, potentially due to these untranslatable codons
This makes Y. lipolytica ATP9 and other mitochondrial genes valuable for studying evolutionary mechanisms of genetic code adaptations and constraints.
Membrane protein expression challenges with ATP9 include:
Challenge | Solution Approach | Rationale |
---|---|---|
Protein aggregation | Expression at lower temperatures (16-20°C) | Reduces expression rate and allows proper folding |
Toxicity to host cells | Tight promoter control | Minimizes leaky expression during growth phase |
Low yield | Codon optimization for E. coli | Addresses translational efficiency issues |
Inclusion body formation | Fusion with solubility tags (beyond His tag) | Enhances protein solubility during expression |
Improper folding | Expression in membrane-mimetic environments | Provides hydrophobic environment necessary for membrane protein folding |
These approaches have been successfully applied to other mitochondrial membrane proteins and can be adapted for ATP9 expression .
For comprehensive functional characterization of ATP9:
Reconstitution into liposomes: Allows assessment of proton translocation function
ATP hydrolysis/synthesis assays: Measures activity when incorporated into complete ATP synthase complexes
Circular dichroism spectroscopy: Determines secondary structure elements and confirms proper folding
Thermal shift assays: Evaluates protein stability under various buffer conditions
Site-directed mutagenesis: Identifies critical residues for c-ring formation and proton translocation
These complementary approaches provide a multi-faceted assessment of ATP9 structural integrity and functional capacity.